No recent analyst price targets found for ORYZF.
Latest News for ORYZF
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025
MADRID and CAMBRIDGE, Mass., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a global leader in epigenetics, today reported financial results for the twelve months ended December 31, 2025 and provided a corporate update on recent developments.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for ORYZF.
Senate Trading
No Senate trades found for ORYZF.
U.S. House Trading
No House trades found for ORYZF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.